Hellman Jordan Management CO Inc Abbott Laboratories Transaction History

Hellman Jordan Management CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $467,339 - $517,014	-4,006 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $177,409 - $208,836	-1,677 Reduced 29.51%	4,006 $464,000
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $618,537 - $728,731	5,683 New	5,683 $681,000
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $5.33 Million - $5.81 Million	-50,800 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $4.66 Million - $5.65 Million	50,800 New	50,800 $5.53 Million

3,175

1.33B

8.62M

7.18M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

Stay updated on Hellman Jordan Management CO Inc with notifications on news.